TILMIUS
LIVE

Serial Number

88816766

Owner

Fresenius Kabi Deutschland GmbH

Attorney

Scott D. Woldow

Filing Date

Mar 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TILMIUS Trademark

Serial Number: 88816766 • Registration: 6727065

TILMIUS is a trademark filed by Fresenius Kabi Deutschland GmbH on March 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Fresenius Kabi Deutschland GmbH (65 trademarks)

Else-Kroener-Str. 1
Bad Homburg 61352 , DE

Entity Type: 16

Trademark Details

Filing Date

March 2, 2020

Registration Date

May 24, 2022

Published for Opposition

July 7, 2020

Goods & Services

Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Apr 12, 2022 TMBN
OPPOSITION TERMINATED NO. 999999
Apr 12, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Apr 12, 2022 OP.D
OPPOSITION INSTITUTED NO. 999999
Oct 27, 2020 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 9, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 29, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 29, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 19, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 20, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 20, 2020 GNSL
SUSPENSION LETTER WRITTEN
Apr 20, 2020 CNSL
ASSIGNED TO EXAMINER
Apr 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2020 NWOS
NEW APPLICATION ENTERED
Mar 5, 2020 NWAP